PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
51.07%
Positive revenue growth while JHX is negative. John Neff might see a notable competitive edge here.
126.19%
Gross profit growth above 1.5x JHX's 4.19%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
81150.00%
EBIT growth above 1.5x JHX's 2.39%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
81150.00%
Operating income growth above 1.5x JHX's 2.39%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
4382.14%
Net income growth above 1.5x JHX's 2.64%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
3260.00%
EPS growth above 1.5x JHX's 2.70%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
3240.00%
Diluted EPS growth above 1.5x JHX's 2.70%. David Dodd would see if there's a robust moat protecting these shareholder gains.
-0.55%
Share reduction while JHX is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.07%
Diluted share count expanding well above JHX's 0.04%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
348.73%
Positive OCF growth while JHX is negative. John Neff would see this as a clear operational advantage vs. the competitor.
222.63%
Positive FCF growth while JHX is negative. John Neff would see a strong competitive edge in net cash generation.
19.40%
10Y revenue/share CAGR under 50% of JHX's 193.57%. Michael Burry would suspect a lasting competitive disadvantage.
-7.17%
Negative 5Y CAGR while JHX stands at 87.77%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
67.54%
3Y revenue/share CAGR 1.25-1.5x JHX's 50.04%. Bruce Berkowitz might see better product or regional expansions than the competitor.
454.70%
10Y OCF/share CAGR above 1.5x JHX's 290.30%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
709.47%
Below 50% of JHX's 2341.92%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
74.50%
Positive 3Y OCF/share CAGR while JHX is negative. John Neff might see a big short-term edge in operational efficiency.
2171.35%
Net income/share CAGR above 1.5x JHX's 998.21% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
262.25%
5Y net income/share CAGR above 1.5x JHX's 149.51%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
527.11%
3Y net income/share CAGR above 1.5x JHX's 61.20%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
100.66%
Below 50% of JHX's 2234.84%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
52.71%
Below 50% of JHX's 823.41%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.29%
Below 50% of JHX's 40.07%. Michael Burry suspects a serious short-term disadvantage in building book value.
165.77%
Stable or rising dividend while JHX is cutting. John Neff sees a strong advantage in consistent shareholder returns vs. a struggling peer.
143.14%
Stable or rising mid-term dividends while JHX is cutting. John Neff sees an edge in consistent payouts vs. the competitor.
50.42%
3Y dividend/share CAGR above 1.5x JHX's 12.44%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
0.55%
Under 50% of JHX's 10.36%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
120.90%
SG&A growth well above JHX's 2.47%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.